DIA426.97-1.07 -0.25%
SPX5,940.46-23.14 -0.39%
IXIC19,142.71-72.75 -0.38%

Clarivate Launches AI-based RiskMark to Accelerate Trademark Conflict Assessments

PR Newswire·05/19/2025 07:00:00
Listen to the news

New AI-based solution empowers trademark professionals to evaluate trademark risk and generate evidence-backed arguments with speed, ease, and confidence

LONDON, May 19, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of RiskMark, an AI-powered solution combining global CompuMark trademark data and Darts-ip litigation data to evaluate trademark risk.

Clarivate logo

Leveraging 172.5 million trademark records spanning 188 jurisdictions and over 5 million global court and administrative records, RiskMark combines generative and predictive AI to transform the process of assessing similarity risk based on relevant evidence. This enables trademark professionals to make strategic decisions and craft arguments with greater speed and confidence. The solution generates near-instant results on visual, phonetic, connotation, and goods and services relatedness to accelerate informed decision-making.

RiskMark also assists customers in argument drafting. With AI-generated arguments, RiskMark provides a strong starting point for drafting opposition responses grounded in legal principles and can help identify insights into potential arguments from opponents.

François Neuville, Senior Vice President, Brand IP, Clarivate, said: "Trademark professionals are under pressure to make critical decisions when creating and protecting brands. Beyond the administrative elements, it is essential to be able to craft arguments for trademark examiners or for litigation based on precedent and following clear legal principles. Our new tool will enable trademark professionals to do this with speed, ease, and confidence. Thanks to our gold-standard data we can empower IP professionals with trustworthy AI-driven insights to assess risk and accelerate drafting, positioning them for both immediate and long-term success."

To learn more, please visit clarivate.com/riskmark.

About Clarivate

Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

Media contact:

Sofia Nogués, Sr. External Communications Manager

newsroom@clarivate.com

 

SOURCE Clarivate Plc

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.